Results and presentations - AstraZeneca
WEB6 days ago · Year-to-date and Q3 2020 results: José Baselga and Mene Pangalos. Year-to-date and Q3 2020: AstraZeneca financial results. Investor science conference call: Farxiga’s DAPA-CKD trial at ESC 2020. Audio replay of Farxiga’s DAPA-HF Investor Conference Call at ESC.
Q1 2024 results - AstraZeneca
WEBApr 25, 2024 · Q1 2024 results. Pascal Soriot, Chief Executive Officer, AstraZeneca, commenting on the results said: “AstraZeneca had a very strong start in 2024 with substantial Total Revenue growth of 19% in the first quarter.
AstraZeneca’s H1 and Q2 2024 Financial Results - Yahoo Finance
WEBJul 25, 2024 · The acquisition bolsters the Alexion, AstraZeneca Rare Disease late-stage pipeline and expands on its bone metabolism franchise with the notable addition of …
AstraZeneca Full year and Q4 2023 Financial Results
WEBFeb 8, 2024 · Total Revenue $45,811m, up 6% despite a decline of $3,736m from COVID-19 medicines4. Excluding COVID-19 medicines, Total Revenue increased 15% and Product Sales increased 14%. Double-digit...
AstraZeneca Q2 results beat estimates; COVID vaccine sales dry up
WEBJul 28, 2023 · AstraZeneca on Friday delivered forecast-beating profits and sales in the second quarter as a strong performance by its blockbuster cancer drugs offset the loss of COVID-19 vaccine sales.
WEBKey milestones achieved since the prior results announcement ‒ Positive read-outs for Imfinzi in combination with chemotherapy in muscle-invasive bladder cancer (NIAGARA), Calquence in untreated mantle cell lymphoma (ECHO), Enhertu in HR-positive, HER2-low metastatic breast cancer (DESTINY-Breast06)
Astrazeneca (AZN) Suffers a Larger Drop Than the General
WEB1 day ago · Market participants will be closely following the financial results of Astrazeneca in its upcoming release. The company's upcoming EPS is projected at $1.07, signifying a 22.99% increase compared ...
AstraZeneca leaps after smashing first-quarter forecasts
WEBApril 25 (Reuters) - AstraZeneca (AZN.L) sailed past market expectations for quarterly revenue and profit on Thursday, boosted by demand for its blockbuster drugs and steady sales from partnered...
AstraZeneca: US data shows vaccine effective for all adults
WEBAstraZeneca said Monday March 22, 2021 that advanced trial data from a U.S. study on its COVID vaccine shows it is 79% effective. The U.S. study comprised 30,000 volunteers, 20,000 of whom were given the vaccine while the rest got dummy shots.
Covid vaccine: AstraZeneca updates US vaccine efficacy results - BBC
WEB25 March 2021. Reuters. AstraZeneca has updated the efficacy result of its coronavirus vaccine trial in the US, after health officials insisted they wanted to include the latest information....